HomeCompareMDVL vs QSR

MDVL vs QSR: Dividend Comparison 2026

MDVL yields 111.11% · QSR yields 3.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDVL wins by $6.05M in total portfolio value
10 years
MDVL
MDVL
● Live price
111.11%
Share price
$1.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.07M
Annual income
$2,192,447.17
Full MDVL calculator →
QSR
QSR
● Live price
3.40%
Share price
$73.76
Annual div
$2.51
5Y div CAGR
-0.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.7K
Annual income
$387.88
Full QSR calculator →

Portfolio growth — MDVL vs QSR

📍 MDVL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDVLQSR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDVL + QSR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDVL pays
QSR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDVL
Annual income on $10K today (after 15% tax)
$9,444.44/yr
After 10yr DRIP, annual income (after tax)
$1,863,580.09/yr
QSR
Annual income on $10K today (after 15% tax)
$289.25/yr
After 10yr DRIP, annual income (after tax)
$329.70/yr
At 15% tax rate, MDVL beats the other by $1,863,250.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDVL + QSR for your $10,000?

MDVL: 50%QSR: 50%
100% QSR50/50100% MDVL
Portfolio after 10yr
$3.05M
Annual income
$1,096,417.52/yr
Blended yield
35.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on QSR right now

MDVL
No analyst data
Altman Z
-14.7
Piotroski
4/9
QSR
Analyst Ratings
27
Buy
15
Hold
2
Sell
Consensus: Buy
Price Target
$81.57
+10.6% upside vs current
Range: $71.00 — $90.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDVL buys
0
QSR buys
0
No recent congressional trades found for MDVL or QSR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDVLQSR
Forward yield111.11%3.40%
Annual dividend / share$2.00$2.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-0.8%
Portfolio after 10y$6.07M$24.7K
Annual income after 10y$2,192,447.17$387.88
Total dividends collected$5.48M$3.7K
Payment frequencyquarterlyquarterly
SectorStockStock

Year-by-year: MDVL vs QSR ($10,000, DRIP)

YearMDVL PortfolioMDVL Income/yrQSR PortfolioQSR Income/yrGap
1← crossover$21,811$11,111.11$11,038$337.57+$10.8KMDVL
2$45,987$22,649.13$12,156$345.43+$33.8KMDVL
3$93,836$44,629.82$13,359$352.69+$80.5KMDVL
4$185,513$85,108.97$14,654$359.36+$170.9KMDVL
5$355,752$157,252.56$16,045$365.45+$339.7KMDVL
6$662,484$281,829.11$17,539$370.97+$644.9KMDVL
7$1,199,347$490,489.82$19,143$375.96+$1.18MMDVL
8$2,113,183$829,881.38$20,863$380.42+$2.09MMDVL
9$3,627,652$1,366,546.40$22,708$384.39+$3.60MMDVL
10$6,074,035$2,192,447.17$24,685$387.88+$6.05MMDVL

MDVL vs QSR: Complete Analysis 2026

MDVLStock

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology. The company's MedCenter enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. It also owns and operates SpotRx, a retail pharmacy platform. As of December 31, 2021, the company had 81 MedCenter kiosks. MedAvail Holdings, Inc. is headquartered in Mississauga, Canada.

Full MDVL Calculator →

QSRStock

Restaurant Brands International Inc. operates as quick service restaurant company in Canada and internationally. It operates through four segments: Tim Hortons (TH), Burger King (BK), Popeyes Louisiana Kitchen (PLK), and Firehouse Subs (FHS). The company owns and franchises TH chain of donut/coffee/tea restaurants that offer blend coffee, tea, and espresso-based hot and cold specialty drinks; and fresh baked goods, including donuts, Timbits, bagels, muffins, cookies and pastries, grilled paninis, classic sandwiches, wraps, soups, and others. It is also involved in owning and franchising BK, a fast food hamburger restaurant chain, which offers flame-grilled hamburgers, chicken and other specialty sandwiches, french fries, soft drinks, and other food items; and PLK quick service restaurants that provide Louisiana style fried chicken, chicken tenders, fried shrimp and other seafood, red beans and rice, and other regional items. In addition, the company owns and franchises FHS restaurants quick service restaurants that offer subs, soft drinks, and local specialties. As of February 15, 2022, the company had approximately 29,000 restaurants in 100 countries under the Tim Hortons, Burger King, Popeyes, And Firehouse Subs brands. Restaurant Brands International Inc. was founded in 1954 and is headquartered in Toronto, Canada.

Full QSR Calculator →
📬

Get this MDVL vs QSR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDVL vs SCHDMDVL vs JEPIMDVL vs OMDVL vs KOMDVL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.